losartan/ hydrochlorothiazide
/ Generic mfg.
- LARVOL DELTA
Home
Next
Prev
1 to 25
Of
53
Go to page
1
2
3
August 29, 2026
Drug-Induced Pancreatitis Associated With Chronic Eluxadoline Use in a Patient With an Intact Gallbladder and Atrophic Pancreas
(ACG 2026)
- "The patient further disclosed use of pancrelipase for pancreatic exocrine insufficiency, losartan-hydrochlorothiazide for hypertension, and chronic eluxadoline use for IBS-D. Contrast-enhanced CT abdomen imaging showing (A) initial findings of a slightly atrophic pancreas with peripancreatic inflammatory changes and no cholecystitis, cholelithiasis, or adrenal or renal mass. Repeat imaging 6 days later shows (B) an atrophic pancreas with moderate peripancreatic fluid and inflammatory stranding extending to the gastric margin."
Clinical • Cardiovascular • Chronic Kidney Disease • Dyslipidemia • Gastroenterology • Gastrointestinal Disorder • Hepatology • Hypertension • Hypertriglyceridemia • Immunology • Pancreatitis
July 07, 2026
EDAM: Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary Intervention
(clinicaltrials.gov)
- P=N/A | N=207 | Recruiting | Sponsor: National Medical Research Center for Therapy and Preventive Medicine
HEOR • New trial • Cardiovascular • Coronary Artery Disease • Hypertension
June 27, 2026
A dual-matrix analytical framework integrating bio-inspired machine learning and Sobol-optimized UV spectrophotometry for five-analyte quantification: comprehensive sustainability assessment.
(PubMed, BMC Chem)
- "In the present study, a dual-matrix chemometric framework was developed for the simultaneous determination of five spectrally overlapping analytes-hydrochlorothiazide (HCD), losartan potassium (LOS), ramipril (RAP), N-nitrosodiethylamine (NDA), and toluene (TLN)-in pharmaceutical formulations and fortified human plasma samples. To the best of our knowledge, no previous UV spectrophotometric chemometric method has been reported for the simultaneous determination of LOS, RAP, and HCD in the presence of both NDA and TLN within a single analytical workflow without a prior separation step. The proposed dual-matrix FA-PLS framework demonstrates that UV spectrophotometry, when coupled with advanced chemometric optimization and statistically designed calibration strategies, can provide an accurate, sensitive, and environmentally sustainable platform for multicomponent pharmaceutical analysis and proof-of-concept application to biological matrices."
Journal
June 06, 2026
Medicaid coverage for fixed-dose combination antihypertensive medications - fifty states and Washington, D.C., 2022.
(PubMed, J Hum Hypertens)
- "Losartan/hydrochlorothiazide had preferred status in 99.3% of plans...Comprehensive coverage was limited. To enhance hypertension control, State Medicaid plans may consider approaches to remove barriers to accessing FDCs."
Journal • Reimbursement • US reimbursement • Cardiovascular • Heart Failure • Hypertension
May 25, 2026
Determination of five antihypertensives in dried capillary plasma spots by LC-MS/MS: A novel method for monitoring pharmacotherapy adherence.
(PubMed, J Pharm Biomed Anal)
- "The residual volume was precipitated using 25% trichloroacetic acid, then mixed with 500 µL methanol containing internal standards (losartan-D4 and atenolol-D7). Lower concentrations of amlodipine, hydrochlorothiazide, and losartan were observed in patients exhibiting poor adherence (n = 21) compared to adherent patients (n = 51) with statistical significance (p < 0.05). The method is promising for assessing antihypertensive adherence using dried plasma spots."
Journal • Cardiovascular • Hypertension
April 06, 2026
WHEN HYPERCALCEMIA SPEAKS: A RARE PRESENTATION OF TRANSFORMED FOLLICULAR LYMPHOMA
(AACE 2026)
- "His medications included losartan-hydrochlorothiazide, cholecalciferol, gabapentin, and opioids. In the presence of elevated calcitriol and suppressed PTH, clinicians must consider high-grade lymphoma in the differential diagnosis. Early recognition and appropriate investigations, including biopsy, molecular testing, and histologic classification, are crucial for guiding diagnosis and treatment decisions."
Endocrine Disorders • Follicular Lymphoma • Hematological Malignancies • Lymphoma • Metabolic Disorders • Non-Hodgkin’s Lymphoma
April 21, 2026
Determinants of Warfarin Metabolism
(clinicaltrials.gov)
- P=N/A | N=1000 | Recruiting | Sponsor: Hadassah Medical Organization | Unknown status ➔ Recruiting | N=600 ➔ 1000 | Trial completion date: Dec 2020 ➔ Dec 2030 | Trial primary completion date: Dec 2020 ➔ Dec 2030
Enrollment change • Enrollment open • Trial completion date • Trial primary completion date • CYP2C9
March 20, 2026
COULD ARTERIOVENOUS FISTULA CREATION TRIGGER A DRAMATIC SPONTANEOUS DOUBLING OF ESTIMATED GLOMERULAR FILTRATION RATE FROM 11 TO 22 ML/MIN/1.73 SQUARE METERS BSA? - CASE REPORT.
(ISN-WCN 2026)
- "At the time, he was on Amlodipine 10 mg/d, Losartan-Hydrochlorothiazide 100-25 mg/d, Spironolactone 25 mg/d, insulin and levothyroxine. Would such improvements in eGFR be related to the mechanics of an AVF creation or would it have any specific causal relationship with the use of the Medtronic Ellipsys Device? Answers to these questions will for now only remain speculative.Our observations call for further inquiry.Similar content was submitted to the American Society of Nephrology 2025 Kidney Week."
Case report • Clinical • Acute Kidney Injury • Cardiovascular • Chronic Kidney Disease • Diabetes • Diabetic Nephropathy • Endocrine Disorders • Hypertension • Metabolic Disorders • Nephrology • Obstructive Sleep Apnea • Renal Disease • Respiratory Diseases • Sleep Apnea • Sleep Disorder
December 05, 2025
Double trouble: The first reported case of evans syndrome following RSV Vaccination
(ASH 2025)
- "Her home medications included amlodipine, losartan, hydrochlorothiazide, and she reported receiving the RSV vaccine one week before admission...The patient was started on presumed ITP treatment with a 1g/kg dose of IVIG and high-dose dexamethasone 40 mg for 4 days...Due to refractory thrombocytopenia, the treatment was shifted to rituximab after the development of hemolytic anemia. The patient received a total of 4 doses weekly, along with a prednisone taper starting at 1 mg/kg, resulting in a slow improvement in her counts back to normal...Evans syndrome ideally requires multidisciplinary care and long-term monitoring due to its chronic, relapsing nature. This case highlights the importance of ongoing pharmacovigilance and educating physicians about immune-mediated hematologic complications that can occur post-vaccination, which are rare but potentially severe."
Clinical • Cardiovascular • Dyslipidemia • Hematological Disorders • Hematological Malignancies • Hepatology • Human Immunodeficiency Virus • Hypertension • Immunology • Infectious Disease • Primary Immunodeficiency • Respiratory Syncytial Virus Infections • Thrombocytopenia • HP
October 18, 2025
Can Arteriovenous Fistula Creation Cause a Dramatic Spontaneous Doubling of Estimated Glomerular Filtration Rate from 11 to 22 mL/min/1.73 m2 Body Surface Area (BSA) in a Span of Five Months? A Case Report
(KIDNEY WEEK 2025)
- "He was on Amlodipine 10 mg/d, Losartan-Hydrochlorothiazide 100-25 mg/d, Spironolactone 25 mg/d, insulin and levothyroxine. What are the implications of this observation? Our observations call for further enquiry."
Case report • Clinical • Acute Kidney Injury • Cardiovascular • Chronic Kidney Disease • Diabetes • Diabetic Nephropathy • Endocrine Disorders • Hypertension • Metabolic Disorders • Nephrology • Obstructive Sleep Apnea • Renal Disease • Respiratory Diseases • Sleep Apnea • Sleep Disorder
September 30, 2025
Emulation of a Target Trial of Antihypertensive Medications on Weight Change.
(PubMed, J Gen Intern Med)
- "We observed small differences in weight change across antihypertensive medications, with lisinopril leading to weight loss and metoprolol and propranolol to modest weight gain. Clinicians should consider potential weight gain when selecting antihypertensive medications."
Journal • Cardiovascular • Hypertension
July 23, 2025
Severe Hemorrhagic Cheilitis as the Initial Manifestation of Systemic Lupus Erythematosus: A Rare Case Report
(EADV 2025)
- "Her regular medications included: losartan, hydrochlorothiazide, and atorvastatin...She was started on oral prednisolone 40 mg daily along with HCQ 200mg after excluding any pre-existing maculopathy... Severe hemorrhagic cheilitis is an uncommon mucocutaneous manifestation of SLE and may be misdiagnosed due to its rarity. In this case, lower lip involvement suggested a potential role of photoaggravation. While management guidelines for oral lupus remain limited, systemic corticosteroids and HCQ showed rapid effectiveness."
Case report • Clinical • Dermatology • Epilepsy • Hematological Disorders • Immunology • Inflammatory Arthritis • Lupus • Macular Degeneration • Musculoskeletal Diseases • Musculoskeletal Pain • Orthopedics • Retinal Disorders • Systemic Lupus Erythematosus
July 23, 2025
A rare case report: Pseudoxanthoma elasticum-like papillary dermal elastolysis
(EADV 2025)
- "Her medical history included type 2 diabetes mellitus and hypertension, managed with metformin, losartan/hydrochlorothiazide, and amlodipine...Treatment with three sessions of intralesional triamcinolone acetonide (10 mg/mL) was initiated... PXE-PDE is a rare and under-recognized condition that requires clinical suspicion and histopathological confirmation. It should be differentiated from PXE to avoid unnecessary systemic investigations. Current treatment options remain limited, and patient response is generally poor."
Case report • Clinical • Cardiovascular • Diabetes • Hypertension • Metabolic Disorders • Type 2 Diabetes Mellitus
July 23, 2025
A rare case report: Pseudoxanthoma elasticum-like papillary dermal elastolysis
(EADV 2025)
- "Her medical history included type 2 diabetes mellitus and hypertension, managed with metformin, losartan/hydrochlorothiazide, and amlodipine...Treatment with three sessions of intralesional triamcinolone acetonide (10 mg/mL) was initiated... PXE-PDE is a rare and under-recognized condition that requires clinical suspicion and histopathological confirmation. It should be differentiated from PXE to avoid unnecessary systemic investigations. Current treatment options remain limited, and patient response is generally poor."
Case report • Clinical • Cardiovascular • Diabetes • Hypertension • Metabolic Disorders • Type 2 Diabetes Mellitus
February 24, 2025
Metformin Associated Lactic Acidosis - A Critical Diagnostic Priority
(ATS 2025)
- "Her home medications included metoprolol, amlodipine, hydrochlorothiazide, losartan, metformin, insulin glargine and aspart. Furthermore, the level of metformin required to cause toxicity has not been clearly defined. IMPORTANCE OF CASE- With metformin's wide usage for DM and Polycystic Ovary Syndrome, and its recent potential as an anti-aging medication, the awareness around MALA should be increased as it can be a devastating condition as demonstrated by this case."
Anemia • Cardiovascular • Diabetes • Hematological Disorders • Hepatology • Hypertension • Infectious Disease • Liver Failure • Metabolic Disorders • Nephrology • Polycystic Ovary Syndrome • Renal Disease • Septic Shock
February 24, 2025
Endocrine Crisis and Obstruction: ACTH-producing Small Cell Lung Cancer Presenting With Superior Vena Cava Syndrome
(ATS 2025)
- "She was started on hydrochlorothiazide-losartan and potassium supplementation...Spironolactone was initiated for hypertension and refractory hypokalemia management...The patient began chemotherapy with cisplatin and etoposide, followed by immunotherapy with durvalumab, and radiation therapy with significant improvement...However, the patient's persistent facial plethora and development of right upper arm swelling, ameliorated by positional changes suggested a concomitant Superior Vena Cava (SVC) syndrome. This case highlights the importance of considering SVC syndrome in the differential diagnosis of a patient who presents with SCLC."
Cardiovascular • Cushing’s Disease • Endocrine Disorders • Hypertension • Lung Cancer • Metabolic Disorders • Myasthenia Gravis • Non Small Cell Lung Cancer • Oncology • Pulmonary Disease • Small Cell Lung Cancer • Solid Tumor
April 27, 2025
Optimizing Blood Pressure Control: A Randomized Comparative Trial of Losartan/Chlorthalidone vs. Losartan/Hydrochlorothiazide.
(PubMed, Cardiol Ther)
- P3 | "The study showed that both combinations are effective for hypertension, with losartan/chlorthalidone demonstrating greater efficacy in reducing diastolic blood pressure and achieving target levels. Both treatments exhibited similar and favorable safety profiles."
Clinical • Journal • Cardiovascular • Hypertension
March 31, 2025
Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients
(clinicaltrials.gov)
- P4 | N=180 | Completed | Sponsor: Shanghai Jiao Tong University School of Medicine | Recruiting ➔ Completed | N=300 ➔ 180 | Trial completion date: May 2024 ➔ Aug 2024 | Trial primary completion date: May 2024 ➔ Aug 2024
Enrollment change • Trial completion • Trial completion date • Trial primary completion date • Cardiovascular • Hypertension
March 11, 2025
Toward a personalized chronotherapy of blood pressure.
(PubMed, Biomed J)
- "Personalized optimization of treatment timing to best match a healthy circadian BP pattern is recommended, guided by chronobiological analyses of ABPM data collected over several days in view of the large day-to-day variability in all features of the 24-hour BP rhythm."
Journal
November 17, 2024
A Rare Case of Pulmonary Edema Secondary to Hydrochlorothiazide Use.
(PubMed, Case Rep Crit Care)
- "Prompt supportive care and discontinuation of the medication is necessary to prevent and manage such a complication. This case report describes a patient who developed noncardiogenic pulmonary edema after taking a combination pill of hydrochlorothiazide-losartan."
Journal • Acute Respiratory Distress Syndrome • Respiratory Diseases
September 27, 2024
Long-term Medication-Induced Weight Change Across Common Antihypertensive Medications
(OBESITY WEEK 2024)
- "We focused on seven commonly prescribed antihypertensives (lisinopril, amlodipine, atenolol, hydrochlorothiazide, losartan, metoprolol, propranolol) and employed a target-trial to assess weight change at 6,12, and 24 months post-initiation. We estimated that initiation and adherence to metoprolol and propranolol would result in the most persistent weight gain over time, and adherence to lisinopril would result in weight loss. Our findings suggest that patients and clinicians should consider weight gain when choosing antihypertensive treatments."
October 12, 2024
Vaping-Induced Acute Tubular Necrosis
(KIDNEY WEEK 2024)
- "His BP medications included amlodipine, Hydrochlorothiazide, and losartan.On exam, he was hypertensive with a BP of 240/130, appeared volume overloaded, and was progressively hypoxic...Healthcare providers should be aware of the risks associated with e-cigarettes, including potential kidney injury.. . ."
Acute Kidney Injury • Cardiovascular • Hematological Disorders • Hypertension • Inflammation • Nephrology • Pain • Renal Disease • Respiratory Diseases • Tobacco Cessation
August 06, 2024
Rare case of photoallergy and leukomelanoderma induced by combined hydrochlorothiazide and losartan therapy
(EADV 2024)
- "Thiazides can induce photosensitivity by a photoallergic or phototoxic mechanism. In our patient, a delayed-onset photoallergy was observed. This reaction has been reported with antihypertensives containing an angiotensin receptor antagonist and hydrochlorothiazide."
Clinical • Atopic Dermatitis • Cardiovascular • Dermatitis • Dermatology • Immunology • Pruritus
August 06, 2024
Deciphering the role of a causative agent: a challenge in the management of bullous dermatosis
(EADV 2024)
- "The list of patient ’ s chronic therapy included vildagliptin/metformin, losartan/hydrochlorothiazide, and atorvastatin, with no alterations up till 8 months before the onset of the skin lesions...Patient was treated with intravenous methylprednisolone 0.5mg/kg/day in a tapering schedule and local corticosteroid ointments, exhibiting substantial improvement, without new lesions erupting. This case highlights the complexity of diagnosing bullous pemphigoid, particularly in the context of its resemblance to other dermatological conditions such as scabies and herpes zoster. The patient ’ s presentation underscores the importance of thorough evaluation and consideration of drug-induced factors in autoimmune diseases, as illustrated in this case, given the fact that almost all of the previously mentioned medications could potentially be the cause of the onset of the disease."
Atopic Dermatitis • Bullous Pemphigoid • Cardiovascular • Dermatology • Dermatopathology • Diabetes • Dyslipidemia • Herpes Zoster • Immunology • Infectious Disease • Metabolic Disorders • Pruritus • Pulmonary Arterial Hypertension • Type 2 Diabetes Mellitus • Urticaria • Varicella Zoster
September 04, 2024
Use and Cost Patterns of Antihypertensive Medications in the United States From 1996 to 2021.
(PubMed, Hypertension)
- "We explored the associations between patent exclusivity loss, per-pill costs, and Medicare Part D enactment on medication use over time, focusing on the most commonly used medications (lisinopril, amlodipine, losartan, hydrochlorothiazide, and metoprolol)...The increase in antihypertensive medication use over the past decades highlights the significant impact of loss of patent exclusivity on the uptake in the use of specific medications. These findings underscore the complexity of factors influencing medication use, beyond cost reductions alone, and suggest that policies need to consider multiple facets to effectively improve antihypertensive medication accessibility and utilization."
Journal • Cardiovascular • Hypertension
1 to 25
Of
53
Go to page
1
2
3